The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk

Diabetologia

Volumn 55, Issue 10, 2012, Pages 2622-2630

  Kaess, B M ^a,b   Pedley, A ^a   Massaro, J M ^c   Murabito, J ^d   Hoffmann, U ^e   Fox, C S ^a,f  

^a FRAMINGHAM HEART STUDY   (United States)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Body fat distribution; Obesity; Risk factors; Subcutaneous fat; Visceral fat

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENERGY METABOLISM; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; INTRAABDOMINAL FAT SUBCUTANEOUS FAT RATIO; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BODY FAT DISTRIBUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; RISK FACTORS; SUBCUTANEOUS FAT;

EID: 84866073021     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2639-5     Document Type: Article

References (32)

1. Mokdad AH, Ford ES, Bowman BA et al (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79 (Pubitemid 36026281)
2. Kaess BM, Jozwiak J, Mastej M et al (2010) Association between anthropometric obesity measures and coronary artery disease: a cross-sectional survey of 16,657 subjects from 444 Polish cities. Heart 96:131-135
3. Liu J, Fox CS, Hickson DA et al (2010) Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 95:5419-5426
4. Fox CS, Massaro JM, Hoffmann U et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39-48 (Pubitemid 47016245)
5. Tran TT, Yamamoto Y, Gesta S, Kahn CR (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410-420 (Pubitemid 351598027)
6. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS (2009) Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32:1068-1075
7. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP (1979) An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110:281-290 (Pubitemid 10204328)
8. Splansky GL, Corey D, Yang Q et al (2007) The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 165:1328-1335 (Pubitemid 47234329)
9. Preis SR, Massaro JM, Robins SJ et al (2010) Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 18:2191-2198
10. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U (2007) Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 31:500-506
11. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881-887 (Pubitemid 46024995)
12. Heilbronn L, Smith SR, Ravussin E (2004) Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 28(Suppl 4):S12-S21 (Pubitemid 40143844)
13. Bjorntorp P (1990) 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496 (Pubitemid 20220571)
14. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K (1995) Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 3(Suppl 2):187S-194S
15. Lee MJ, Gong DW, Burkey BF, Fried SK (2010) Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. Am J Physiol Endocrinol Metab 300:E571-E580
16. Miyazaki Y, Mahankali A, Matsuda M et al (2002) Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87:2784-2791 (Pubitemid 34655345)
17. Akazawa S, Sun F, Ito M, Kawasaki E, Eguchi K (2000) Efficacy of troglitazone on body fat distribution in type 2 diabetes. Diabetes Care 23:1067-1071 (Pubitemid 30618043)
18. Nakamura T, Funahashi T, Yamashita S et al (2001) Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation - double-blind placebo-controlled trial. Diabetes Res Clin Pract 54:181-190 (Pubitemid 33016325)
19. Yang X, Smith U (2007) Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 50:1127-1139 (Pubitemid 46701551)
20. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J (1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351:871-875 (Pubitemid 28121176)
21. Troll JG (2011) Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection. Curr Atheroscler Rep 13:51-56
22. Carr A, Samaras K, Burton S et al (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51-F58 (Pubitemid 28190689)
23. Gastaldelli A, Sironi AM, Ciociaro D et al (2005) Visceral fat and beta cell function in non-diabetic humans. Diabetologia 48:2090-2096 (Pubitemid 41416921)
24. Molenaar EA, Massaro JM, Jacques PF et al (2009) Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: the Framingham Heart Study. Diabetes Care 32:505-510
25. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315:1305-1309 (Pubitemid 17030406)
26. Faulds MH, Zhao C, Dahlman-Wright K, Gustafsson JA (2012) The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol 212:3-12
27. Perkins KA, Epstein LH, Marks BL, Stiller RL, Jacob RG (1989) The effect of nicotine on energy expenditure during light physical activity. N Engl J Med 320:898-903 (Pubitemid 19101594)
28. Mineur YS, Abizaid A, Rao Y et al (2011) Nicotine decreases food intake through activation of POMC neurons. Science 332:1330-1332
29. Miyazaki Y, DeFronzo RA (2009) Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol 8:44
30. He H, Ni Y, Chen J et al (2011) Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res 155:71-77
31. Gorgey AS, Mather KJ, Gater DR (2011) Central adiposity associations to carbohydrate and lipid metabolism in individuals with complete motor spinal cord injury. Metabolism 60:843-851
32. Kim S, Cho B, Lee H et al (2011) Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a Korean population. Diabetes Care 34:504-506